Over at Terra Sigillata, David Kroll (you may also know him by his old nom-de-blog, Abel Pharmboy), wrote a nice blog post about my profile of research outsourcer Quintiles and its founder and chief executive, Dennis Gillings, in the current issue of Forbes.
FORBES: More On Quintiles' Pharmaceutical Investments